Transforming Science into Medicine
아이디언스, AACR서 항암신약 후보 '베나다파립'연구 결과 발표
아이디언스 항암제 후보물질 IDX-1197 美FDA IND 통과
Idience is a science-driven biopharmaceutical company that changes oncology patients’ quality of life.
Learn about our key pipeline of PARP inhibitor
Meet the leadership team at Idience
Explore our clinical trials of PARP inhibitor
Join our team if you share our values, our dedication to patients and our passion for science